New Data: Rebates are Unrelated to Drugmakers’ Pricing Strategies
August 15, 2018
(Washington, D.C.) — As the Administration considers modifying price concessions for prescription drugs in Medicare and federal programs, the Pharmaceutical Care...
PCMA Statement on Administration’s Step to Reduce Drug Costs in Medicare Part B
August 07, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association issued the following statement on today’s announcement by the Administration to reduce...
PCMA Supports Legislation to Ensure Patients Pay Lowest Price for Prescription Drugs
July 24, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on S. 2554, the...
PCMA EVENTS
PCMA hosts three annual events: the sPCMA Business Forum, the PBM Policy Forum, and the PCMA Annual Meeting
PCMA’s conference brand is known for bringing together thought leaders and pharmacy benefit decision makers from PBMs, specialty pharmacies, and pharma and biotech manufacturers.
Learn MoreABOUT OUR INDUSTRY
PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.